Compare Entegris Inc (ENTG) vs Stryker Corporation (SYK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Entegris Inc vs Stryker Corporation — how do they compare? Entegris Inc trades at $133.78 (market cap $21.12B), while Stryker Corporation trades at $329.04 (market cap $121.31B). The key difference: Stryker Corporation is far larger — about 5.7× Entegris Inc's market cap, and Stryker Corporation pays the higher dividend (1.11%). Which is the better fit depends on your goals.
| ENTG | SYK | |
|---|---|---|
Market Cap | $21.12B | $121.31B |
Sector | Technology | Technology |
52-Week High | $184.00 | $403.53 |
52-Week Low | $68.80 | $282.58 |
Enterprise Value | $24.44B | $133.07B |
Dividend Yield | 0.29% | 1.11% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ENTG trades at $134.15, down 4.61% today, with technical indicators showing bearish momentum as the stock approaches key support at $133. The company maintains solid fundamentals with Q1 2026 earnings beating estimates at $0.86 per share and strong analyst consensus of 65% buy ratings. Recent developments include a $0.10 dividend declaration and new CFO appointment, while semiconductor industry tailwinds from AI-driven demand provide growth catalysts.
ENTG presents a compelling opportunity with 25% upside to the $178.40 consensus price target, supported by improving cash flow trends and semiconductor sector growth. However, elevated valuation multiples (P/E 80.17) and technical bearish signals warrant caution amid recent price volatility and competitive pressures in the semiconductor materials space.
Stryker (SYK) trades at $329.38, up 5.84% in the last session, yet technical indicators signal a bearish trend. The company reported a Q1 2026 earnings miss due to a temporary cyber disruption but maintained full-year guidance, with strong profitability margins and robust cash flow. Recent news highlights expansion of its Mako robotics platform, reinforcing its innovation-led growth strategy in the medical technology sector.
The investment outlook is positive based on strong fundamentals and analyst consensus, but near-term risks include competitive pressures and execution challenges. With a consensus price target of $388.44 representing ~18% upside, the stock offers value for long-term investors, though volatility may persist until Q2 earnings clarify the post-disruption recovery.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Entegris Inc
Entegris Inc is a supplier of advanced materials and process solutions for the semiconductor and other high-technology industries. The company's reportable segments include Specialty Chemicals & Engineered Materials (SCEM), Microcontamination Control (MC), and Advanced Materials Handling (AMH). The SCEM segment provides high-performance & high-purity process chemistries, gases, & materials, and safe & efficient delivery systems. The Microcontamination Control (MC) segment includes solutions to purify critical liquid chemistries and process gases used in semiconductor manufacturing processes and other high-technology industries. Its geographical segments are Taiwan, North America, South Korea, Japan, China, Europe, and Southeast Asia.
Read more on ENTG →About Stryker Corporation
Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.
Read more on SYK →
